PRADAXA DABIGATRAN 150MG – 60 CAPS

Pradaxa (dabigatran etexilate) is an oral anticoagulant medication primarily used for the prevention and treatment of thromboembolic disorders. It is commonly prescribed for patients with non-valvular atrial fibrillation to reduce the risk of stroke and systemic embolism. Additionally, Pradaxa is utilized for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) following surgery, particularly hip or knee replacement surgery.

Pradaxa works by directly inhibiting thrombin, an enzyme crucial for blood clot formation, thereby preventing the development of clots. Its advantages include a rapid onset of action, no need for routine monitoring of coagulation levels, and fewer dietary restrictions compared to traditional anticoagulants like warfarin. However, it is essential for patients to be aware of potential bleeding risks associated with its use. The standard dosage is 150 mg, taken twice daily, and it is available in a bottle of 60 capsules.